CABA

Cabaletta Bio Inc
12.1001
-0.0899 (-0.74%)
Company Name Stock Ticker Symbol Market Type
Cabaletta Bio Inc CABA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0899 -0.74% 12.1001 14:46:23
Open Price Low Price High Price Close Price Prev Close
11.94 11.94 12.48 12.19
more quote information »

Recent News

Date Time Source Heading
1/09/202307:02EDGARCurrent Report Filing (8-k)
1/09/202307:00GLOBEAutolus Therapeutics Announces Collaboration with Cabaletta..
1/05/202308:00GLOBECabaletta Bio to Present at the 41st Annual J.P. Morgan..
12/23/202216:16EDGARStatement of Ownership (sc 13g)
12/12/202216:53EDGARCurrent Report Filing (8-k)
12/08/202216:32EDGARCurrent Report Filing (8-k)
12/08/202207:11EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/08/202207:07EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
12/08/202207:00GLOBECabaletta Bio Announces $35 Million Offering
11/22/202208:00GLOBECabaletta Bio to Present at the 5th Annual Evercore ISI..
11/13/202209:25TRMNChardan Capital Sticks to Their Buy Rating for Cabaletta Bio..
11/11/202206:26TRMNH.C. Wainwright Sticks to Their Buy Rating for Cabaletta Bio..
11/10/202216:35TRMNMizuho Securities Reaffirms Their Buy Rating on Cabaletta..
11/10/202207:42EDGARQuarterly Report (10-q)
11/10/202207:09EDGARCurrent Report Filing (8-k)
11/10/202207:00GLOBECabaletta Bio Reports Third Quarter 2022 Financial Results..
11/07/202216:33EDGARStatement of Ownership (sc 13g)
10/31/202216:41EDGARStatement of Ownership (sc 13g)
10/31/202216:02EDGARStatement of Ownership (sc 13g)
10/11/202216:35TRMNMizuho Securities Reaffirms Their Buy Rating on Cabaletta..
10/11/202212:41TRMNAnalysts Have Conflicting Sentiments on These Healthcare..
10/11/202207:15EDGARCurrent Report Filing (8-k)
10/11/202207:00GLOBECabaletta Bio Announces CABA-201, a Newly Designed..
10/06/202208:00GLOBECabaletta Bio to Present at the 29th Annual Congress of the..
9/26/202208:00GLOBECabaletta Bio to Present at the Chardan 6th Annual Genetic..
9/12/202206:10EDGARCurrent Report Filing (8-k)
9/11/202217:55TRMNMizuho Securities Reaffirms Their Buy Rating on Cabaletta..
9/10/202207:00GLOBECabaletta Bio Presents New Interim Data from the DesCAARTes™..
9/06/202208:00GLOBECabaletta Bio to Participate in Upcoming Investor..
8/29/202214:15EDGARCurrent Report Filing (8-k)
8/29/202213:58GLOBECabaletta Bio to Present Data at the 31st EADV Congress and..
8/22/202208:50EDGARStatement of Ownership (sc 13g)
8/15/202204:05TRMNChardan Capital Keeps Their Buy Rating on Cabaletta Bio..
8/11/202220:15TRMNMizuho Securities Sticks to Its Buy Rating for Cabaletta Bio..
8/11/202207:42EDGARQuarterly Report (10-q)
8/11/202207:16EDGARCurrent Report Filing (8-k)
8/11/202207:00GLOBECabaletta Bio Reports Second Quarter 2022 Financial Results..
8/03/202217:02EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
6/03/202216:47EDGARStatement of Changes in Beneficial Ownership (4)
6/03/202216:47EDGARStatement of Changes in Beneficial Ownership (4)
6/03/202216:47EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202208:00EDGARCurrent Report Filing (8-k)
5/24/202220:25TRMNMizuho Securities Sticks to Their Buy Rating for Cabaletta..
5/22/202204:10TRMNH.C. Wainwright Thinks Cabaletta Bio’s Stock is Going to..
5/18/202210:10TRMNMizuho Securities Keeps a Buy Rating on Cabaletta Bio (CABA)
5/18/202207:07EDGARCurrent Report Filing (8-k)
5/18/202207:00GLOBECabaletta Bio Presents Updated Interim DesCAARTes™ Trial..
5/17/202208:00GLOBECabaletta Bio to Present at the H.C. Wainwright Global..
5/16/202206:15TRMNH.C. Wainwright Thinks Cabaletta Bio’s Stock is Going to..
5/12/202217:35TRMNMizuho Securities Sticks to Its Buy Rating for Cabaletta Bio..